Tuberculosis & HIV/AIDS: Treatment
- An Overview of Isoniazid (INH, Nydrazid) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials (July 24, 2009)
A brief recap of selected mainstream media coverage of research presented at IAS 2009.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- d4T Toxicity Risk 7-Fold Higher When Started With TB Treatment (June 18, 2009)
From aidsmap.com
- South Africa Tries Treating TB Patients at Home (March 24, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission (March 24, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Tuberculosis Treatments and Drugs (January 28, 2009)
From Mayo Clinic
- FDA Issues "Black Box" Warning for Cipro, Similar Drugs (July 9, 2008)
From Project Inform
- Mycobacterium Tuberculosis: Treatment in the United States and Other High-Income Nations (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
- International Standards for Tuberculosis Care (PDF) (2006)
Diagnosis, treatment, public health.
From World Health Organization
- Tuberculosis Treatment in Resource-Limited Settings (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
- Virtual Medicine: Web-Based Record System Proves as Potent as Drugs in Treating Tuberculosis (August 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Tuberculosis Treatment Pipeline (July 2005)
To read PDF, click here
From Treatment Action Group
- An Overview of Rifampin (Rifadin, Rimactane) (February 10, 2005)
To read PDF, click here
From U.S. National Institutes of Health
- Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
[Archived Article]
To read PDF, click here
From U.S. Food and Drug Administration
- Mycobacterium tuberculosis Disease (December 17, 2004)
A chapter from "Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents" guidelines.
To read PDF, click here
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
- Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors (January 20, 2004)
To read PDF, click here
From U.S. Centers for Disease Control and Prevention
- Surgeon General: Treatment in Prison Can Prevent Disease Outside (January 13, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Tuberculosis Treatment Evolves (October 2003)
[Archived Article]
New guidelines reflect subtle but important shifts in strategy.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Avoid Rifampin/Pyrazinamide Treatment in TB Patients, CDC Says (August 8, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Treatment of Tuberculosis (June 20, 2003)
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
- Technology Transfer Will Allow Countries to Produce Own TB Drugs (June 5, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Treatment of HIV-Related Tuberculosis (May 2003)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite Knowledge Base Chapter
- Scale Up the Global Fight Against Tuberculosis (March 28, 2003)
[Archived Article]
Excerpts from an op-ed column by Gro Harlem Brundtland, director-general of the World Health Organization, and James D. Wolfensohn, president of the World Bank.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Directly Observed Treatment Short Course for TB: A Treatment to Match a Killer Infection (March 27, 2003)
[Archived Article]
Excerpts from an editorial in the Akron Beacon Journal.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Controlling Tuberculosis in India (November 25, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Treatment of Tuberculosis (PDF) (October 2002)
[Archived Article]
Revised guidelines from the American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society of America.
- New Drugs Sought for Top Killer of Young Women Worldwide (July 31, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- African Treatment Programs Often Overestimate Tuberculosis Drug Doses (May 17, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Notice to Readers: Acquired Rifamycin Resistance in Persons With Advanced HIV Disease Being Treated for Active Tuberculosis With Intermittent Rifamycin-Based Regimens (March 15, 2002)
[Archived Article]
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
- Tuberculosis: Guidelines Changed for Latent TB Treatment (September 21, 2001)
[Archived Article]
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
- The Georgia TB Reference Guide (PDF) (September 2001)
[Archived Article]
From Atlanta Tuberculosis Prevention Coalition
- Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations -- United States, 2001 (PDF) (August 31, 2001)
[Archived Article]
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
- Severe Liver Damage With TB Drugs (May 29, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- An Inexpensive Antibiotic Proves Effective in Reducing Death Among People With HIV and TB in Africa (May 1999)
[Archived Article]
From U.S. Centers for Disease Control and Prevention
- A New Treatment for TB (June 1998)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
- A Short Two-Drug Regimen Prevents Active TB (April 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- New Two-Month TB Prophylaxis Regimen Is as Effective as Yearlong Therapy (April 1998)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
- Guidelines for the Administration of Protease Inhibitors and Rifampin in HIV-Positive Patients With Tuberculosis (October 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- TB or Not TB: Do You Have Tuberculosis? (October 1997)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
- The Challenge of Multidrug-Resistant Tuberculosis (October 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Tuberculosis Therapy and the New Protease Inhibitors (November 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- A History of TB Treatment (July 23, 1996)
[Archived Article]
From New Jersey Medical School
- Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children (January 1, 1994)
[Archived Article]
In American Journal of Respiratory and Critical Care Medicine, from American Lung Association
|
|
Advertisement
|
E-Mail
Glossary
Share
